To include your compound in the COVID-19 Resource Center, submit it here.

Mighty mitochondria

How MDNA’s mitochondrial markers could diagnose diseases earlier

MDNA Life Sciences Inc. thinks circulating mitochondrial DNA holds the key to early, non-invasive detection of a host of diseases. Having launched its first mitochondrial-based diagnostic in October - a prostate cancer blood test dubbed Prostate Mitomic Test - the company is pushing ahead with a suite of mitochondrial biomarkers for a variety of cancers and other diseases. Next up is endometriosis.

MDNA CEO Christopher Mitton told BioCentury that endometriosis is a

Read the full 717 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers